PMI VectorLink Guinea

Malaria is endemic in Guinea, with stable and perennial transmission. Malaria is the leading cause of health facilities visits, with the entire populace at risk of the disease. It is estimated that between 2006 and 2016, about 934,165 outpatient visits were due to malaria every year. Children under 5 and pregnant women, the two most vulnerable groups, represent 37% and 5% respectively of the total malaria cases recorded between 2014 and 2016 (Malaria National Strategic Plan 2018–2023).

Insecticide-treated nets (ITNs) are distributed for children under 5 and pregnant women through antenatal care visits and the country’s expanded immunization programs. Mass campaigns are organized every three years to maintain high coverage and use of ITNs in Guinea. School-based net distribution, the community, and the private sector are additional channels used to increase ITN availability and use. The use of insecticide-treated nets among children under 5 and pregnant women increased from 26% and 28% in 2012 to 68% and 54% respectively in 2016 (MICS, 2016). In addition, mining companies in selected sous prefectures implement indoor residual spraying.

Activities and accomplishments:

• PMI VectorLink Guinea trained 13 health workers from the NMCP to carry out insecticide resistance monitoring and vector bionomics monitoring.
• The project assessed the susceptibility of local vectors to pyrethroids, neonicotinoid, pyrroles, and organophosphates. This data was used to recommend the procurement of Dual-AI or PBO ITNs countrywide.
• PMI VectorLink supported the NMCP to transition the Integrated Malaria Technical Working Group to an Integrated Vector Control Technical Working Group.

Capacity Building
Financing & Economics
Insecticide Resistance
Leadership & Governance
Vector Control

Mar 2021 — Mar 2023

Guinea

The PMI VectorLink Project